(20S)-7-tert-butyldimethysilyl-10-hydroxycamptothecin

(20S)-7-tert-butyldimethysilyl-10-hydroxycamptothecin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2017-07-13 00:00:00
Sponsor Vivacitas Oncology, Inc.;1990 North California Boulevard, 8th Floor;Walnut Creek, California, 94596
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM